Arkolith/Insider Trading/QLGN/Form 4

Kruger Kurt H

DirectorQualigen Therapeutics, Inc. (QLGN) · full profile →Form 4 · filed Aug 20, 2021
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2021Buy(P)4K$1.23$5K14K
Aug 19, 2021Buy(P)4K$1.22$5K18K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-020787) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML